Clinical Trial Update: Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy

View source ↗

Summary

The clinical trial update summarizes cardiovascular risk outcomes in growth hormone deficient young adult males after completing growth hormone therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Growth hormone therapy (somatropin)

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Growth Hormone Deficiency | Status: COMPLETED